Ad hoc announcement pursuant to Art. 53 LR Broad indication in HR+/HER2- stage II and III early breast cancer (EBC) at high risk of recurrence approximately doubles population eligible for CDK4/6 ...

Presented at the San Antonio Breast Cancer Symposium; December 7-10, 2021; San Antonio, USA. 21. Iqbal J, Ginsburg O, Rochon PA, Sun P, Narod SA. Differences in breast cancer stage at diagnosis and ...

AstraZeneca and Daiichi Sankyo’s antibody-drug conjugate (ADC) Enhertu is already making waves in breast cancer, and clinical results presented at the San Antonio Breast Cancer Symposium (SABCS ...

HealthDay News — US cancer incidence trends improved in 2021, but continued to be lower than expected, according to a study published online September 6 in JAMA Network Open. Todd Burus ...

The San Antonio Breast Cancer Symposium (SABCS) has highlighted some of the most promising clinical research being undertaken by drugmakers in the category, with AstraZeneca leading the charge ...

Black women are about 40% more likely to die of breast cancer than White women, but new research is showing this applies to all forms of the disease — and examines why. In the study, published ...

Ray Fisher gets a prostate specific antigen test administered outside the UCSF Helen Diller Family Comprehensive Cancer Center during an SF CAN event in 2022. Photo by Maurice Ramirez “Later,” James ...

Ad hoc announcement pursuant to Art. 53 LR Broad indication in HR+/HER2- stage II and III early breast cancer (EBC) at high risk of recurrence approximately doubles population eligible for CDK4/6 inhi ...

He joined STAT in 2021 after covering health and science at NPR and NPR affiliate stations. His work has been recognized by national Edward R. Murrow awards, the June L. Biedler prize for cancer ...

SAN DIEGO (KGTV) — For Sebastian Cruz-Sanchez, getting ready for the day doesn't just mean getting his backpack ready for school. Right now, the San Diego High School junior has a full plate and ...